Comparison of a commercial real-time PCR assay for tcdB detection to a cell culture cytotoxicity assay and toxigenic culture for direct detection of toxin-producing Clostridium difficile in clinical samples.
about
Diagnostic accuracy of loop-mediated isothermal amplification in detection of Clostridium difficile in stool samples: a meta-analysisLaboratory diagnosis of Clostridium difficile infection can molecular amplification methods move us out of uncertainty?Molecular diagnosis of diarrhea: current status and future potentialEvaluation of an automated rapid diagnostic test for detection of Clostridium difficile.Impact of strain type on detection of toxigenic Clostridium difficile: comparison of molecular diagnostic and enzyme immunoassay approaches.Diagnostic accuracy of real-time polymerase chain reaction in detection of Clostridium difficile in the stool samples of patients with suspected Clostridium difficile Infection: a meta-analysis.Clostridium difficile: epidemiology, pathogenesis, management, and prevention of a recalcitrant healthcare-associated pathogen.Rapid stool-based diagnosis of Clostridium difficile infection by real-time PCR in a children's hospital.Comparison of five assays for detection of Clostridium difficile toxin.The emergence of Clostridium difficile infection among peripartum women: a case-control study of a C. difficile outbreak on an obstetrical service.Evaluation of a loop-mediated isothermal amplification assay for diagnosis of Clostridium difficile infections.Perirectal swab surveillance for Clostridium difficile by use of selective broth preamplification and real-time PCR detection of tcdBLoop-mediated isothermal amplification compared to real-time PCR and enzyme immunoassay for toxigenic Clostridium difficile detection.Sensitive quantification of Clostridium difficile cells by reverse transcription-quantitative PCR targeting rRNA molecules.Clinical and laboratory evaluation of a real-time PCR for Clostridium difficile toxin A and B genes.The Daniel K. Inouye College of Pharmacy Scripts: Updates on Clostridium difficile Infection: Advances in Laboratory Testing to Aid Diagnosis and Treatment.Comparison of BD GeneOhm Cdiff and Seegene Seeplex ACE PCR assays using toxigenic Clostridium difficile culture for direct detection of tcdB from stool specimens.Comparison of a frozen human foreskin fibroblast cell assay to an enzyme immunoassay and toxigenic culture for the detection of toxigenic Clostridium difficile.The potential economic value of screening hospital admissions for Clostridium difficile.Recognition and prevention of hospital-associated enteric infections in the intensive care unitDiagnosis of Clostridium difficile infection: an ongoing conundrum for clinicians and for clinical laboratories.Comparison of nine commercially available Clostridium difficile toxin detection assays, a real-time PCR assay for C. difficile tcdB, and a glutamate dehydrogenase detection assay to cytotoxin testing and cytotoxigenic culture methods.Clostridium difficile in solid organ transplant recipients.Clostridium difficile in paediatric populations.Real-time cellular analysis coupled with a specimen enrichment accurately detects and quantifies Clostridium difficile toxins in stool.Nosocomial diarrhea: a review of pathophysiology, etiology, and treatment strategies.Superiority of the DNA amplification assay for the diagnosis of C. difficile infection: a clinical comparison of fecal tests.Molecular techniques for diagnosis of Clostridium difficile infection: systematic review and meta-analysis.Clostridium difficile: Changing Epidemiology, Treatment and Infection Prevention Measures.Molecular methods in the diagnosis of Clostridium difficile infections: an update.Comparison of Simplexa universal direct PCR with cytotoxicity assay for diagnosis of Clostridium difficile infection: performance, cost, and correlation with disease.Diagnosis of Clostridium difficile infection: comparison of four methods on specimens collected in Cary-Blair transport medium and tcdB PCR on fresh versus frozen samples.Real-time cellular analysis for quantitative detection of functional Clostridium difficile toxin in stool.The prevalence of Clostridium difficile infection in pediatric and adult patients with inflammatory bowel disease.Comparison of Illumigene, Simplexa, and AmpliVue Clostridium difficile molecular assays for diagnosis of C. difficile infection.Colonization with toxinogenic C. difficile upon hospital admission, and risk of infection: a systematic review and meta-analysis.Clostridium Difficile Infection from a Surgical Perspective.Challenges in fecal donor selection and screening for fecal microbiota transplantation: A review.Premarket evaluations of the IMDx C. difficile for Abbott m2000 Assay and the BD Max Cdiff AssayOptimizing the diagnostic testing of Clostridium difficile infection.
P2860
Q26777157-118FE200-B167-48D1-8765-536E4ABAEAA6Q26827536-66924721-BC7A-4B53-BE4B-9F1F527FE70CQ30422560-79E3BE6A-0AB4-495C-AC9F-9ECB858DEB50Q34110313-8CFA65F6-EB07-4F6B-9635-21D16DDEAAC9Q34190375-491AA242-170C-41A0-9BEB-D03F1A3D51B8Q34213457-5BB1F214-C159-419E-9331-0E567C0FD779Q34638198-CFE6D286-9233-4631-B36B-FF34EBF74098Q34741501-38D86A98-FE78-483E-BE51-C56ED5DFF918Q35069904-76019D13-835F-493A-87AC-DC2ED67CDE8BQ35137718-50FB059C-D689-43D6-9266-BF1174638ABCQ35140090-D6109285-D67C-4CB0-9D13-E3EF7E402D6EQ35530491-D39978F2-2804-49D0-A043-41AFEBF53104Q35807076-879BE196-B3EA-4085-A709-BE7EF0231A62Q36155874-5166EA7B-FA14-472C-B0EB-7D67D5454A8AQ36162408-3FAB80B8-862F-4F68-AA7A-497C396C3203Q36283755-859585D7-DE30-4907-AD25-8E9342572A7FQ36363103-E5E0AF86-504E-41FF-954B-5BBAFAFD2C59Q36476718-DFCA817B-7091-45F6-B8C8-FCDEAAB0FA38Q36582287-FA112C79-879D-4B34-AF7F-DCFD7F480CAFQ36853756-4C844D6E-8478-4D02-BF1C-BBD3F7C15FF7Q37035829-DB3B3C5F-92FD-4913-86AB-9F9E4F2BD56CQ37374873-58AB4C2E-9D6D-4234-87A1-5B26689A4769Q37507177-BF056230-C8C8-4C5A-99EF-486AE6E708E3Q37609568-D6B062A4-BEB5-4805-96E0-1E1021B5DB35Q37713428-87A1F3CF-7095-4A3C-A794-A0F553D1DCF2Q37992488-F05826CA-56A5-441D-861F-60A8B8DA9E9CQ38009242-DC3BDCDD-13D9-4065-8601-F4F27DD38746Q38024184-8CA730AB-5A15-4986-9D36-FA5A24E37BC8Q38051245-ACEAD031-4AC5-48D3-A190-A791333C4546Q38142247-87B54C8D-0BBA-4461-AF9B-BDD83635EFC6Q38162391-65ED6B67-A2AF-4056-B99B-D914EE6C5426Q38182579-9BDF1735-213F-4445-9C5C-B9D76C99D99AQ38197671-5FD99ED7-02DD-4DE1-9462-82DEDEEC9868Q38208694-19A236FF-3241-496B-A9F4-7F53DD1DD11BQ38323052-C6D4D29B-C2B4-4A1D-9110-61AD8E2A53EBQ38366858-3F8AF2FD-9DEA-4E55-A018-12292920F3B6Q38445227-38AAFB74-175E-4F6A-9A36-D3001150ABA0Q38764998-F50DF250-E501-434A-ABD5-54777BF3029CQ38858185-8FA3E26D-A8C6-4E25-82E3-A3C9FA307469Q38909959-10E69710-EBBC-4A3F-B899-2AA3F07F6F9C
P2860
Comparison of a commercial real-time PCR assay for tcdB detection to a cell culture cytotoxicity assay and toxigenic culture for direct detection of toxin-producing Clostridium difficile in clinical samples.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Comparison of a commercial rea ...... difficile in clinical samples.
@en
Comparison of a commercial rea ...... difficile in clinical samples.
@nl
type
label
Comparison of a commercial rea ...... difficile in clinical samples.
@en
Comparison of a commercial rea ...... difficile in clinical samples.
@nl
prefLabel
Comparison of a commercial rea ...... difficile in clinical samples.
@en
Comparison of a commercial rea ...... difficile in clinical samples.
@nl
P2093
P2860
P356
P1476
Comparison of a commercial rea ...... difficile in clinical samples.
@en
P2093
Deborah Aird
Ijeoma Ikpeama
Jennifer Wehrlin
Karen C Carroll
Paul D Stamper
Romina Alcabasa
Wisal Babiker
P2860
P304
P356
10.1128/JCM.01613-08
P407
P577
2008-12-10T00:00:00Z